NICE guidance app

NICE launches new guidance app

pharmafile | March 20, 2012 | News story | Medical Communications, Sales and Marketing Android, Apple, NICE, app, digital, guidance 

NICE has launched a new app that allows mobile access to all of NICE’s recommendations and advice of the past 12 years.

The pricing watchdog said the new app had been developed in response to demand from users of NICE guidance.

More than 760 pieces of NICE guidance are contained, such as clinical guidelines on COPD, hypertension and stroke, and the app is automatically updated for new appraisals.

Guidance is arranged by clinical or public health topic, and particular sections can be bookmarked for easy access, or sent via email. 

Other features include receiving automatic updates and new guidance as soon as it is published on the NICE website, adjustable font size for readability.

Jane Gizbert, communications director at NICE, said: “For the first time, doctors, nurses and other users of NICE guidance will be able to access recommendations from NICE wherever they are through NICE’s new, official app.

“The app will provide offline access to all of NICE’s guidance products, including clinical guidelines, public health guidance, technology appraisals, interventional procedures guidance, medical technology and diagnostics guidance.

“Users will also be able to bookmark sections for easy access, and email sections to themselves or colleagues.”

She added: “The guidance app marks the first in a series of proposed app developments from NICE, which will eventually cover medicines and prescribing information, NICE Pathways and other NICE products.”

The NICE Guidance app works on Android Smartphones, Apple iPhones and iPod touch running IOS 4.3 and above and can be downloaded from Apple’s iStore and the Android Market.

While the app can be downloaded for the iPad, it is not currently optimised for it, so iPad users wishing to access NICE guidance should access the Pathways instead. 

Ben Adams 

Related Content

NHS-integrated pharmacy app Charac receives £1.2m funding

Charac, an NHS-integrated pharmacy app, has raised £1.2m in debt and equity financing from the …

Novo Nordisk launches Wegovy in the UK

Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK …

Amicus Therapeutics’ Pompe disease treatment approved for use in UK

Amicus Therapeutics has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the …

Latest content